Effect of SAENGCHINYANGHYOLTANG on the serum lipid composition in streptozotocin-induced diabetic rats

생진양혈탕(生津養血湯)이 고혈당(高血糖) 쥐의 혈중지질성분(血中脂質成分)에 미치는 영향(影響)

  • Kim, Shin-Seok (College of Oriental Medicine, Tae Jon University,College of Pharmacy, Kyungsung University) ;
  • Choi, Jong-Won (College of Oriental Medicine, Tae Jon University,College of Pharmacy, Kyungsung University) ;
  • Lee, Kyung-Hee (Dept. of Food Science and Nutrition, Dong-A University) ;
  • Lee, Cheol-Whan (Dept. of Food Science and Nutrition, Dong-A University)
  • 김신석 (대전대학교 한의과대학,경성대학교 약학대학) ;
  • 최종원 (대전대학교 한의과대학,경성대학교 약학대학) ;
  • 이경희 (동아대학교 식품영양학과) ;
  • 이철완 (동아대학교 식품영양학과)
  • Published : 1995.10.30

Abstract

The purpose of this study was to investigate the effect of pretreatment with Saegchinyanghyoltang(SYT) on the serum lipid composition and atherosclerotic index in streptozotocin(STZ)-induced diabetic rats. SYT pretreatment in STZ-induced diabetic rats inhibited the rise of serum glucose concentration. Serum total lipids and triglyceride levels in the STZ -induced diabetic rats were significantly higher than those in the control group. But in the group pretreated with SYT, triglyceride and lipid levels were significantly lower compared with those of STZ -induced diabetic rat group without STZ. However, the serum phospholipid levels were not statistically different among treatment groups. In the STZ-induced diabetic group, the serum total cholesterol, VLDL-, LDL-cholesterol levels and atherosclerotic index Were higher and HDL-cholesterol level was lower compared to the control group. However, these changes were prevented by SYT pretreatment Pretreatment with SYT significantly increased the activities of serum lipase compared to the STZ-treated group.

Keywords

References

  1. 古今醫方集成 吳克潛
  2. 東醫寶鑑 許浚
  3. 沈氏尊生書 沈金鰲
  4. 聖濟總錄 趙估
  5. 大韓醫學全集 李正來
  6. 古今醫方集成 江克潛
  7. 漢方內科學 李基渟
  8. 中醫內科學 上海中醫學院
  9. 實用中醫內科學 實用中醫內科學編纂委員會
  10. 實用中西醫綜合診斷 陳貴延;楊思樹(主編)
  11. Ann. Rev. Biochem. v.46 Control mechanism in the synthesis of saturated fatty acids Bloch, K.;Vance, D.
  12. J. Lipid Res. v.19 Lipoprotein apoprotein metabolism Schaefer, E.J.;Eisenberg, S.;Levy, R.I.
  13. Ann. rev. Biochem. v.52 Fatty acid synthesis and its regulation Wakil, S.J.;Stoops, J.K.;Joshi, V.C.
  14. 慶熙大學校大學阮 漢醫大 博士論文 消渴에 應用되는 白虎湯이 Alloxan 精尿에 미치는 影響 金完熙
  15. 慶熙漢醫大 論文集 v.7 加味六味地黃湯이 streptozotocin 白鼠의 血糖量에 미치는 影響 許鐘會
  16. 慶熙大學校 大學院 博士學位論文 加味地黃湯과 오석초 實驗的 糖尿에 미치는 影響 鄭大奎
  17. 大韓漢醫學會誌 v.15 no.2 高血糖 쥐의 膵臟酵素活性에 미치는 生津養血湯의 影響 金信錫;催鐘元;李哲浣
  18. 方藥合編 黃度淵
  19. Ann. Clin. Biochem. v.6 Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor Trinder, P.
  20. Metabolism v.13 Serum pyruvate and lactate in uremia Galloway, R.E.;Morgan, J.M.
  21. Textbook of clinical chemistry Lipids, lipoproteins and apolipoproteins Sten, E.A.
  22. Clin. Chem. v.29 A peroxidase-coupled method for the colorimetric determination of serum triglycerides McGowan, M.W.;Artiss, J.D.;Strandbergh, D.R.
  23. Anal. Chem. v.28 Microdetermination of phos-phorus Chen, P.S.;Toribara, T.Y.;Warner, H.
  24. Am. J. Med. v.62 High density lipoprotein as a protective factor against coronary heart disease Cordon, T.;Castelli, W.P.;Hjortland, M.C.;Kannel, W.B.;Dawber, T.R.
  25. Clin. Chem. v.18 Estimation of concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge Fridewald, W.T.;Levy, R.I.;Fedreicson, D.S.
  26. Clin. Chem. v.17 A rapid and reliable measurement of serum lipase activity Yang, J.S.;Biggs, H.G.
  27. Biochem. Pharmacol. v.34 no.6 Effect of streptozotocin on the glutathion S-transferse of mouse liver cytosol Charles, A.;Anthony, S.G.
  28. Experimentia v.44 Effect of niacin/nicotinamide deficiency on the diabetogenic effet of streptozotocin Wright, J.R.;Mendola, J.;Lacy, P.E.
  29. Diabetes v.37 Mechanism of nicotinamide and thymidine protection from alloxan and streptozotocin toxicity Susan, P.L.;Carolyn, R.H.;Pam, M.F.;Nancy, J.P.;Glenn, L.W.
  30. Adv. Enzymol. v.44 The role of surface carbohydrate in the hepatic recognition and transport of circulating glycoprotein Ashwell, G.;Morell, A.G.
  31. Diabetes v.24 Physiologic mechanisms in the development of starvation ketosis in man Grey, N.J.;Karls, I.;Kipnis, D.M.
  32. New Engl. J. Med. v.309 The metabolic derangements and treatment of diabetic ketoacidosis Foster, D.W.;McGarry, J.D.
  33. Am. J. Med. v.58 Familial hypercholesterolemia. A genetic regulatory defect in cholesterol metabolism Goldstein, J.L.;Brown, M.S.
  34. Lipids v.13 The evidence for the antiatherogenicity of high density lipoproteinin man Miller, N.E.
  35. New Engl. J. Med. v.314 the phatogenesis of atherosclerosis An update Ross, R
  36. Lipoproteins and lipid transport Metabolic control and disease(8th ed.) Havel, R.J.;Goldstein, J.L.;Brown, M.S.
  37. Ann. Rev. Biochem. v.49 Regulation of hepatic fatty acid oxidation and ketone body production McGarry, J.D.;Foster, D.W.
  38. Br. J. Clin. Pharmac. v.18 Drug metabolism in diabetic subjects with fatty livers Pittiaho, H.I.;Salmela, P.I.;Sotaniemi, E.A.;Pelkonen, R.O.;Pitkanen, U.;Luoma, P.V.